Ancker OV, Krüger M, Wehland M, Infanger M, Grimm D (2019) Multikinase inhibitor treatment in thyroid Cancer. Int J Mol Sci 21(1). https://doi.org/10.3390/ijms21010010

Annibaldi A, Dousse A, Martin S, Tazi J, Widmann C (2011) Revisiting G3BP1 as a RasGAP binding protein: sensitization of tumor cells to chemotherapy by the RasGAP 317–326 sequence does not involve G3BP1. PLoS ONE 6(12):e29024. https://doi.org/10.1371/journal.pone.0029024

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bian P, Hu W, Liu C, Li L (2020) Resveratrol potentiates the anti-tumor effects of rapamycin in papillary thyroid cancer: PI3K/AKT/mTOR pathway involved. Arch Biochem Biophys 689:108461. https://doi.org/10.1016/j.abb.2020.108461

Article  CAS  PubMed  Google Scholar 

Carnero A, Blanco-Aparicio C, Renner O, Link W, Leal JF (2008) The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Curr Cancer Drug Targets 8(3):187–198. https://doi.org/10.2174/156800908784293659

Article  CAS  PubMed  Google Scholar 

Chen JM, Bai JY, Yang KX (2018a) Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway. IUBMB Life 70(6):491–500. https://doi.org/10.1002/iub.1749

Article  CAS  PubMed  Google Scholar 

Chen Y, Wang T, Du J, Li Y, Wang X, Zhou Y, Wang Y (2018b) The critical role of PTEN/PI3K/AKT signaling pathway in Shikonin-Induced apoptosis and proliferation inhibition of chronic myeloid leukemia. Cell Physiol Biochem 47(3):981–993. https://doi.org/10.1159/000490142

Article  CAS  PubMed  Google Scholar 

Chmielik E, Rusinek D, Oczko-Wojciechowska M, Jarzab M, Krajewska J, Czarniecka A, Jarzab B (2018) Heterogeneity of thyroid Cancer. Pathobiology 85(1–2):117–129. https://doi.org/10.1159/000486422

Article  PubMed  Google Scholar 

Choudhuri S, Klaassen CD (2006) Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters. Int J Toxicol 25(4):231–259. https://doi.org/10.1080/10915810600746023

Article  CAS  PubMed  Google Scholar 

Cui B, Yang Q, Guan H, Shi B, Hou P, Ji M (2014) PRIMA-1, a mutant p53 reactivator, restores the sensitivity of TP53 mutant-type thyroid cancer cells to the histone methylation inhibitor 3-Deazaneplanocin A. J Clin Endocrinol Metab 99(6):E962–970. https://doi.org/10.1210/jc.2013-3147

Article  CAS  PubMed  Google Scholar 

Doyle L, Ross DD (2003) Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 22(47):7340–7358. https://doi.org/10.1038/sj.onc.1206938

Article  CAS  PubMed  Google Scholar 

Fetsch PA, Abati A, Litman T, Morisaki K, Honjo Y, Mittal K, Bates SE (2006) Localization of the ABCG2 mitoxantrone resistance-associated protein in normal tissues. Cancer Lett 235(1):84–92. https://doi.org/10.1016/j.canlet.2005.04.024

Article  CAS  PubMed  Google Scholar 

Haddadi N, Lin Y, Travis G, Simpson AM, Nassif NT, McGowan EM (2018) PTEN/PTENP1: ‘Regulating the regulator of RTK-dependent PI3K/Akt signalling’, new targets for cancer therapy. Mol Cancer 17(1):37. https://doi.org/10.1186/s12943-018-0803-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Han GH, Chay DB, Yi JM, Cho H, Chung JY, Kim JH (2019) Loss of both USP10 and p14ARF protein expression is an independent prognostic biomarker for poor prognosis in patients with epithelial ovarian Cancer. Cancer Genomics Proteomics 16(6):553–562. https://doi.org/10.21873/cgp.20157

Article  CAS  PubMed  PubMed Central  Google Scholar 

He Y, Jiang S, Mao C, Zheng H, Cao B, Zhang Z, Mao X (2021) The deubiquitinase USP10 restores PTEN activity and inhibits non-small cell lung cancer cell proliferation. J Biol Chem 297(3):101088. https://doi.org/10.1016/j.jbc.2021.101088

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu C, Zhang M, Moses N, Hu CL, Polin L, Chen W, Zhang XM (2020) The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53. Cell Death Dis 11(5):328. https://doi.org/10.1038/s41419-020-2519-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim K, Huh T, Park Y, Koo DH, Kim H, Hwang I, Chung JY (2020) Prognostic significance of USP10 and p14ARF expression in patients with colorectal cancer. Pathol Res Pract 216(6):152988. https://doi.org/10.1016/j.prp.2020.152988

Article  CAS  PubMed  Google Scholar 

Laha D, Nilubol N, Boufraqech M (2020) New therapies for advanced thyroid Cancer. Front Endocrinol (Lausanne) 11:82. https://doi.org/10.3389/fendo.2020.00082

Article  PubMed  Google Scholar 

Lampada A, O’Prey J, Szabadkai G, Ryan KM, Hochhauser D, Salomoni P (2017) mTORC1-independent autophagy regulates receptor tyrosine kinase phosphorylation in colorectal cancer cells via an mTORC2-mediated mechanism. Cell Death Differ 24(6):1045–1062. https://doi.org/10.1038/cdd.2017.41

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu XH, Chen GG, Vlantis AC, Tse GM, van Hasselt CA (2010) Iodine induces apoptosis via regulating MAPKs-related p53, p21, and Bcl-xL in thyroid cancer cells. Mol Cell Endocrinol 320(1–2):128–135. https://doi.org/10.1016/j.mce.2010.02.004

Article  CAS  PubMed  Google Scholar 

Liu H, Deng H, Zhao Y, Li C, Liang Y (2018) LncRNA XIST/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling. J Exp Clin Cancer Res 37(1):279. https://doi.org/10.1186/s13046-018-0950-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu R, Chen Y, Liu G, Li C, Song Y, Cao Z, Liu Y (2020) PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers. Cell Death Dis 11(9):797. https://doi.org/10.1038/s41419-020-02998-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu L, Zhao T, Shan L, Cao L, Zhu X, Xue Y (2021) Estradiol regulates intestinal ABCG2 to promote urate excretion via the PI3K/Akt pathway. Nutr Metab (Lond) 18(1):63. https://doi.org/10.1186/s12986-021-00583-y

Article  CAS  PubMed  Google Scholar 

Lopez JP, Wang-Rodriguez J, Chang C, Chen JS, Pardo FS, Aguilera J, Ongkeko WM (2007) Gefitinib inhibition of drug resistance to doxorubicin by inactivating ABCG2 in thyroid cancer cell lines. Arch Otolaryngol Head Neck Surg 133(10):1022–1027. https://doi.org/10.1001/archotol.133.10.1022

Article  PubMed  Google Scholar 

Magne F, Ge B, Larrivée-Vanier S, Van Vliet G, Samuels ME, Pastinen T, Deladoëy J (2016) Demonstration of autosomal monoallelic expression in thyroid tissue assessed by whole-exome and bulk RNA sequencing. Thyroid 26(6):852–859. https://doi.org/10.1089/thy.2016.0009

Article  CAS  PubMed  Google Scholar 

Ouchida AT, Kacal M, Zheng A, Ambroise G, Zhang B, Norberg E, Vakifahmetoglu-Norberg H (2018) USP10 regulates the stability of the EMT-transcription factor Slug/SNAI2. Biochem Biophys Res Commun 502(4):429–434. https://doi.org/10.1016/j.bbrc.2018.05.156

Article  CAS  PubMed  Google Scholar 

Po A, Citarella A, Catanzaro G, Besharat ZM, Trocchianesi S, Gianno F, Ferretti E (2020) Hedgehog-GLI signalling promotes chemoresistance through the regulation of ABC transporters in colorectal cancer cells. Sci Rep 10(1):13988. https://doi.org/10.1038/s41598-020-70871-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rittler D, Baranyi M, Molnár E, Garay T, Jalsovszky I, Varga IK, Hegedűs B (2019) The Antitumor Effect of Lipophilic Bisphosphonate BPH1222 in Melanoma Models: the role of the PI3K/Akt pathway and the small G protein Rheb. Int J Mol Sci 20(19). https://doi.org/10.3390/ijms20194917

Robey RW, To KK, Polgar O, Dohse M, Fetsch P, Dean M, Bates SE (2009) ABCG2: a perspective. Adv Drug Deliv Rev 61(1):3–13. https://doi.org/10.1016/j.addr.2008.11.003

Article  CAS  PubMed  Google Scholar 

Robey RW, Pluchino KM, Hall MD, Fojo AT, Bates SE, Gottesman MM (2018) Revisiting the role of ABC transporters in multidrug-resistant cancer. Nat Rev Cancer 18(7):452–464. https://doi.org/10.1038/s41568-018-0005-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Seib CD, Sosa JA (2019) Evolving understanding of the epidemiology of thyroid Cancer. Endocrinol Metab Clin North Am 48(1):23–35. https://doi.org/10.1016/j.ecl.2018.10.002

Article  PubMed  Google Scholar 

Shi X, Valizadeh A, Mir SM, Asemi Z, Karimian A, Majidina M, Yosefi B (2020) miRNA-29a reverses P-glycoprotein-mediated drug resistance and inhibits proliferation via up-regulation of PTEN in colon cancer cells. Eur J Pharmacol 880:173138. https://doi.org/10.1016/j.ejphar.2020.173138

Article  CAS  PubMed  Google Scholar 

Singh RR, Kunkalla K, Qu C, Schlette E, Neelapu SS, Samaniego F, Vega F (2011) ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma. Oncogene 30(49):4874–4886. https://doi.org/10.1038/onc.2011.195

Article  CAS  PubMed  PubMed Central  Google Scholar 

Soltani A, Torki S, Ghahfarokhi MS, Jami MS, Ghatrehsamani M (2019) Targeting the phosphoinositide 3-kinase/AKT pathways by small molecules and natural compounds as a therapeutic approach for breast cancer cells. Mol Biol Rep 46(5):4809–4816. https://doi.org/10.1007/s11033-019-04929-x

Article